“… 8 FCM is rapidly emerging for real-time microscopic assessment of resection margins in various surgical fields including for skin tumors, urological neoplasms, and prostate cancer 9 , 10 ; and for immediate diagnosis in different organs such as colon, prostate, and thyroid. 11 , 12 , 13 , 14 FCM appears particularly appealing for rapid bedside evaluation of small specimens, such as image-guided fine-needle aspiration biopsy, core needle biopsy, and endoscopic biopsy. 15 , 16 Recently, a method to subject pancreatic EUS-FNA/FNB samples to FCM evaluation was reported based on a polymeric scaffold (Cytomatrix, UCS Diagnostic, Morlupo, Italy) as a holder to keep specimens under the FCM objective and maintain cellular material and fragments during subsequent FFPE preparation.…”